Home > Newsletters > Clinical Trials Advisor > UK Industry Groups Update Guidance on Insurance for Phase I Trials
Clinical Trials Advisor
Aug. 2, 2012 | Vol. 17 No. 15
UK Industry Groups Update Guidance on Insurance for Phase I Trials
UK sponsors of Phase I clinical trials should take out adequate insurance policies in order to accelerate ethics committee review processes and assure volunteers they will be compensated for an injury or adverse event suffered as a result of the study, according to a new industry best practice guideline.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.